The PRESIDE (PhaRmacogEnomicS In DEpression) Trial: a double-blind randomised controlled trial of pharmacogenomic-informed prescribing of antidepressants on depression outcomes in patients with major depressive disorder in primary care
Volume:
Issue:
Year of Publication: 2023
Statistics
Citations : 2Authors : 0
Identifiers
Doi : 10.1186/s13063-023-07361-6SSN :